Moderna CEO Stephane Bancel believes the personalized mRNA cancer vaccine being developed with Merck will work in a variety of tumors. Speaking with Romaine Bostick on "Bloomberg The Close," Bancel also says the recent data leak for the cancer vaccine candidate did not come from either Moderna or Merck. (Source: Bloomberg)
Mostramos la idea principal publicamente. Crea una cuenta gratis para seguir leyendo el articulo completo, guardarlo, comentarlo y conectarlo con contexto de mercados y OSINT.